Nanoparticle-based Therapeutics for Brain Cancer and CNS Disorders
Nanocarry is developing therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. The company’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2…